Safety of New Formulation of Glatiramer Acetate (Song)
- Study Title
- Safety of New Formulation of Glatiramer Acetate
- Teva Identifier
- PM033
- ClinicalTrials.gov Identifier
- NCT00947752
- Study Status
- Completed
- Trial Condition(s)
- Relapsing Remitting Multiple Sclerosis
- Interventions
- Drug: Glatiramer Acetate | Drug: Experimental Glatiramer Acetate
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 07/01/2009 - 11/01/2009
- Phase
- Phase 3
